Yoshikawa Keisuke, Kuwahara Motoi, Saigoh Kazumasa, Ishiura Hiroyuki, Yamagishi Yuko, Hamano Yuta, Samukawa Makoto, Suzuki Hidekazu, Hirano Makito, Mitsui Yoshiyuki, Tsuji Shoji, Kusunoki Susumu
Departmentof Neurology, Faculty of Medicine, Kindai University, Japan.
Department of Life Science, Faculty of Science and Engineering, Kindai University, Japan.
eNeurologicalSci. 2018 Nov 22;14:34-37. doi: 10.1016/j.ensci.2018.11.026. eCollection 2019 Mar.
Spastic paraplegia 30 is a recently established autosomal recessive disease characterized by a complex form of spastic paraplegia associated with neuropathy. Homozygous mutations of reportedly lead to hereditary spastic paraplegia or hereditary sensory and autonomic neuropathy type 2 (HSAN2), whereas heterozygous mutations can cause nonsyndromic and syndromic intellectual disability (MRD9). Here we report the case of a 37-year-old female who presented with gait disturbance complicated with moyamoya disease.
The patient exhibited hypotonia during infancy, after which intellectual disability, epileptic fits, spastic paraplegia, and cerebellar atrophy occurred. Genetic analysis revealed a novel mutation (c.254C > A, p.A85D) in the motor domain of .
痉挛性截瘫30型是一种最近确定的常染色体隐性疾病,其特征为伴有神经病变的复杂形式的痉挛性截瘫。据报道, 基因的纯合突变会导致遗传性痉挛性截瘫或2型遗传性感觉和自主神经病变(HSAN2),而杂合突变可引起非综合征性和综合征性智力障碍(MRD9)。在此,我们报告一例37岁女性病例,该患者表现为步态障碍并伴有烟雾病。
该患者在婴儿期表现为肌张力减退,之后出现智力障碍、癫痫发作、痉挛性截瘫和小脑萎缩。基因分析显示 基因运动域存在一个新的突变(c.254C > A,p.A85D)。